Vitamin D deficiency and pregnancy: From preconception to birth

Molecular Nutrition and Food Research

Volumn 54, Issue 8, 2010, Pages 1092-1102

  Lewis, Sharon ^a   Lucas, Robyn M ^b   Halliday, Jane ^a,c   Ponsonby, Anne Louise ^a  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b The Australian National University   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Antenatal; Development; Postnatal; Pregnancy; Vitamin D

Indexed keywords

VITAMIN D;

ANIMAL; DIET SUPPLEMENTATION; FEMALE; FEMALE INFERTILITY; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRENATAL DEVELOPMENT; REVIEW; VITAMIN D DEFICIENCY;

ANIMALS; DIETARY SUPPLEMENTS; FEMALE; HUMANS; INFERTILITY, FEMALE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 77955865776     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201000044     Document Type: Review

References (129)

1. Holick, M. F., McCollum Award Lecture, 1994: vitamin D-new horizons for the 21st century. Am. J. Clin. Nutr. 1994, 60, 619-630.
2. Lucas, R. M., Ponsonby, A. L., Pasco, J. A., Morley, R., Future health implications of prenatal and early-life vitamin D status. Nutr. Rev. 2008, 66, 710-720.
3. Armas, L. A., Hollis, B. W., Heaney, R. P., Vitamin D2 is much less effective than vitamin D3 in humans. J. Clin. Endocrinol. Metab. 2004, 89, 5387-5391.
4. Holick, M. F., MacLaughlin, J. A., Clark, M. B., Holick, S. A. et al., Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science 1980, 210, 203-205.
5. Nowson, C. A., Margerison, C., Vitamin D intake and vitamin D status of Australians. Med. J. Aust. 2002, 177, 149-152.
6. Holick, M. F., Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am. J. Clin. Nutr. 2004, 80, 1678S-1688S.
7. Bikle, D., Nonclassic actions of vitamin D. J. Clin. Endocrinol. Metab. 2009, 94, 26-34.
8. Holick, M. F., Vitamin D status: measurement, interpretation, and clinical application. Ann. Epidemiol. 2009, 19, 73-78.
9. Evans, K. N., Bulmer, J. N., Kilby, M. D., Hewison, M., Vitamin D and placental-decidual function. J. Soc. Gynecol. Invest. 2004, 11, 263-271.
10. Lips, P., Vitamin D physiology. Prog. Biophys. Mol. Biol. 2006, 92, 4-8.
11. Ceglia, L., Vitamin D and skeletal muscle tissue and function. Mol. Aspects Med. 2008, 29, 407-414.
12. DeLuca, H. F., Zierold, C., Mechanisms and functions of vitamin D. Nutr. Rev. 1998, 56, S4-S10; discussion S54-S75.
13. Maalouf, N. M., The noncalciotropic actions of vitamin D: recent clinical developments. Curr. Opin. Nephrol. Hypertens. 2008, 17, 408-415.
14. Chiu, K. C., Chu, A., Go, V. L., Saad, M. F., Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am. J. Clin. Nutr. 2004, 79, 820-825.
15. Smith, M. A., McHenry, C., Oslapas, R., Hofmann, C. et al., Altered TSH levels associated with increased serum 1,25- dihydroxyvitamin D3: a possible link between thyroid and parathyroid disease. Surgery 1989, 106, 987-991.
16. Achinger, S. G., Ayus, J. C., The role of vitamin D in left ventricular hypertrophy and cardiac function. Kidney Int. Suppl. 2005, S37-42.
17. Abe, E., Miyaura, C., Sakagami, H., Takeda, M. et al., Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3. Proc. Natl. Acad. Sci. USA 1981, 78, 4990-4994.
18. Eisman, J. A., Koga, M., Sutherland, R. L., Barkla, D. H. et al., 1,25-Dihydroxyvitamin D3 and the regulation of human cancer cell replication. Proc. Soc. Exp. Biol. Med. 1989, 191, 221-226.
19. DeLuca, H. F., Evolution of our understanding of vitamin D. Nutr. Rev. 2008, 66, S73-S87.
20. Shimizu, K., Kawase, A., Haneishi, T., Kato, Y. et al., Novel vitamin D3 antipsoriatic antedrugs: 16-En-22-oxa- 1alpha,25-(OH)2D3 analogs. Bioorg. Med. Chem. 2006, 14, 1838-1850.
21. Szodoray, P., Nakken, B., Gaal, J., Jonsson, R. et al., The complex role of vitamin D in autoimmune diseases. Scand. J. Immunol. 2008, 68, 261-269.
22. Daniel, C., Sartory, N. A., Zahn, N., Radeke, H. H. et al., Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J. Pharmacol. Exp. Ther. 2008, 324, 23-33.
23. Mulligan, M. L., Felton, S. K., Riek, A. E., Bernal-Mizrachi, C., Implications of vitamin D deficiency in pregnancy and lactation. Am. J. Obst. Gynecol. 2009, DOI: 10.1016/j.ajog.2009.09.0002.
24. Specker, B., Vitamin D requirements during pregnancy. Am. J. Clin. Nutr. 2004, 80, 1740S-1747S.
25. Perez-Lopez, F. R., Vitamin D: the secosteroid hormone and human reproduction. Gynecol. Endocrinol. 2007, 23, 13-24.
26. Abrams, S. A., In utero physiology: role in nutrient delivery and fetal development for calcium, phosphorus, and vitamin D. Am. J. Clin. Nutr. 2007, 85, 604S-607S.
27. Salle, B. L., Delvin, E. E., Lapillonne, A., Bishop, N. J. et al., Perinatal metabolism of vitamin D. Am. J. Clin. Nutr. 2000, 71, 1317S-1324S.
28. Ardawi, M. S., Nasrat, H. A., HS, B. A. A., Calciumregulating hormones and parathyroid hormone-related peptide in normal human pregnancy and postpartum: a longitudinal study. Eur. J. Endocrinol./Eur. Fed. Endocr. Soc. 1997, 137, 402-409.
29. Ritchie, L. D., Fung, E. B., Halloran, B. P., Turnlund, J. R. et al., A longitudinal study of calcium homeostasis during human pregnancy and lactation and after resumption of menses. Am. J. Clin. Nutr. 1998, 67, 693-701.
30. Kovacs, C. S., Vitamin D in pregnancy and lactation: maternal, fetal, and neonatal outcomes from human and animal studies. Am. J. Clin. Nutr. 2008, 88, 520S-528S.
31. Kovacs, C. S., Kronenberg, H. M., Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr. Rev. 1997, 18, 832-872.
32. Zehnder, D., Evans, K. N., Kilby, M. D., Bulmer, J. N. et al., The ontogeny of 25-hydroxyvitamin D(3) 1alpha-hydroxylase expression in human placenta and decidua. Am. J. Pathol. 2002, 161, 105-114.
33. Delvin, E. E., Glorieux, F. H., Salle, B. L., David, L. et al., Control of vitamin D metabolism in preterm infants: feto-maternal relationships. Arch. Dis. Child. 1982, 57, 754-757.
34. Markestad, T., Aksnes, L., Ulstein, M., Aarskog, D., 25-Hydroxyvitamin D and 1,25-dihydroxyvitamin D of D2 and D3 origin in maternal and umbilical cord serum after vitamin D2 supplementation in human pregnancy. Am. J. Clin. Nutr. 1984, 40, 1057-1063.
35. Novakovic, B., Sibson, M., Ng, H. K., Manuelpillai, U. et al., Placenta-specific methylation of the vitamin D 24-hydroxylase gene: implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface. J. Biol. Chem. 2009, 284, 14838-14848.
36. 22nd Marabou Symposium, The changing faces of vitamin D. Nutr. Rev. 2008, 66, S195-S212.
37. Maghbooli, Z., Hossein-Nezhad, A., Shafaei, A. R., Karimi, F. et al., Vitamin D status in mothers and their newborns in Iran. BMC Pregnancy Childbirth 2007, 7, 1.
38. Zittermann, A., Dembinski, J., Stehle, P., Low vitamin D status is associated with low cord blood levels of the immunosuppressive cytokine interleukin-10. Pediatr. Allergy Immunol. 2004, 15, 242-246.
39. Pichler, J., Gerstmayr, M., Szepfalusi, Z., Urbanek, R. et al., 1 alpha,25(OH)2D3 inhibits not only Th1 but also Th2 differentiation in human cord blood T cells. Pediatr. Res. 2002, 52, 12-18.
40. Liu, N., Kaplan, A. T., Low, J., Nguyen, L. et al., Vitamin D induces innate antibacterial responses in human trophoblasts via an intracrine pathway. Biol. Reprod. 2009, 80, 398-406.
41. Smith, S. E., Li, J., Garbett, K., Mirnics, K. et al., Maternal immune activation alters fetal brain development through interleukin-6. J. Neurosci. 2007, 27, 10695-10702.
42. Correale, J., Ysrraelit, M. C., Gaitan, M. I., Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain 2009, 132, 1146-1160.
43. Holick, M. F., Environmental factors that influence the cutaneous production of vitamin D. Am. J. Clin. Nutr. 1995, 61, 638S-645S.
44. Matsuoka, L. Y., Wortsman, J., Haddad, J. G., Hollis, B. W., Skin types and epidermal photosynthesis of vitamin D3. J. Am. Acad. Dermatol. 1990, 23, 525-526.
45. Matsuoka, L. Y., Wortsman, J., Hanifan, N., Holick, M. F., Chronic sunscreen use decreases circulating concentrations of 25-hydroxyvitamin D. A preliminary study. Arch. Dermatol. 1988, 124, 1802-1804.
46. van der Meer, I. M., Karamali, N. S., Boeke, A. J., Lips, P. et al., High prevalence of vitamin D deficiency in pregnant non-Western women in The Hague, Netherlands. Am. J. Clin. Nutr. 2006, 84, 350-353.
47. Grover, S. R., Morley, R., Vitamin D deficiency in veiled or dark-skinned pregnant women. Med. J. Aust. 2001, 175, 251-252.
48. Genuis, S. J., Schwalfenberg, G. K., Hiltz, M. N., Vaselenak, S. A., Vitamin D status of clinical practice populations at higher latitudes: analysis and applications. Int. J. Environ. Res. Public Health 2009, 6, 151-173.
49. Bischoff-Ferrari, H. A., Kiel, D. P., Dawson-Hughes, B., Orav, J. E. et al., Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among U.S. adults. J. Bone Miner. Res. 2009, 24, 935-942.
50. Hollis, B. W., Wagner, C. L., Assessment of dietary vitamin D requirements during pregnancy and lactation. Am. J. Clin. Nutr. 2004, 79, 717-726.
51. Lapillonne, A., Vitamin D deficiency during pregnancy may impair maternal and fetal outcomes. Med. Hypotheses 2009.
52. Farrant, H. J., Krishnaveni, G. V., Hill, J. C., Boucher, B. J. et al., Vitamin D insufficiency is common in Indian mothers but is not associated with gestational diabetes or variation in newborn size. Eur. J. Clin. Nutr. 2009, 63, 646-652.
53. Mallet, E., Gugi, B., Brunelle, P., Henocq, A.et al., Vitamin D supplementation in pregnancy: a controlled trial of two methods. Obstet. Gynecol. 1986, 68, 300-304.
54. Datta, S., Alfaham, M., Davies, D. P., Dunstan, F. et al., Vitamin D deficiency in pregnant women from a non-European ethnic minority population - an interventional study. BJOG 2002, 109, 905-908.
55. Canadian_Paediatric_Society, Vitamin D supplementation: recommendations for Canadian mothers and infants [Position Statement (FNIM 2007-01)]. Paediatr. Child Health 2007, 12, 583-589.
56. Hollis, B. W., Wagner, C. L., Vitamin D deficiency during pregnancy: an ongoing epidemic. Am. J. Clin. Nutr. 2006, 84, 273.
57. IARC, World Health Organisation International Agency for Research on Cancer 2008.
58. Vieth, R., Bischoff-Ferrari, H., Boucher, B. J., Dawson-Hughes, B. et al., The urgent need to recommend an intake of vitamin D that is effective. Am. J. Clin. Nutr. 2007, 85, 649-650.
59. Halloran, B. P., DeLuca, H. F., Effect of vitamin D deficiency on fertility and reproductive capacity in the female rat. J. Nutr. 1980, 110, 1573-1580.
60. Panda, D. K., Miao, D., Tremblay, M. L., Sirois, J. et al., Targeted ablation of the 25-hydroxyvitamin D 1alpha - hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc. Natl Acad. Sci. USA 2001, 98, 7498-7503.
61. Kinuta, K., Tanaka, H., Moriwake, T., Aya, K. et al., Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. Endocrinology 2000, 141, 1317-1324.
62. Johnson, L. E., DeLuca, H. F., Vitamin D receptor null mutant mice fed high levels of calcium are fertile. J. Nutr. 2001, 131, 1787-1791.
63. Ozkan, S., Jindal, S., Greenseid, K., Shu, J. et al., Replete vitamin D stores predict reproductive success following in vitro fertilization. Fertil. Steril. 2009, DOI: 10.1016/j.fertnstert.2009.05.019.
64. Potashnik, G., Lunenfeld, E., Levitas, E., Itskovitz, J. et al., The relationship between endogenous oestradiol and vitamin D3 metabolites in serum and follicular fluid during ovarian stimulation for in-vitro fertilization and embryo transfer. Hum. Reprod. 1992, 7, 1357-1360.
65. Cervera, R., Balasch, J., Bidirectional effects on autoimmunity and reproduction. Hum. Reprod. Update 2008, 14, 359-366.
66. Orbach, H., Zandman-Goddard, G., Amital, H., Barak, V. et al., Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann. NY Acad. Sci. 2007, 1109, 385-400.
67. Kotsa, K., Yavropoulou, M. P., Anastasiou, O., Yovos, J. G., Role of vitamin D treatment in glucose metabolism in polycystic ovary syndrome. Fertil. Steril. 2009, 92, 1053-1058.
68. Thys-Jacobs, S., Donovan, D., Papadopoulos, A., Sarrel, P. et al., Vitamin D and calcium dysregulation in the polycystic ovarian syndrome. Steroids 1999, 64, 430-435.
69. Sibai, B., Dekker, G., Kupferminc, M., Pre-eclampsia. Lancet 2005, 365, 785-799.
70. Taufield, P. A., Ales, K. L., Resnick, L. M., Druzin, M. L. et al., Hypocalciuria in preeclampsia. N. Engl. J. Med. 1987, 316, 715-718.
71. Hofmeyr, G. J., Atallah, A. N., Duley, L., Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane database Syst. Rev. 2006, 3, CD001059.
72. Levine, R. J., Hauth, J. C., Curet, L. B., Sibai, B. M. et al., Trial of calcium to prevent preeclampsia. N. Engl. J. Med. 1997, 337, 69-76.
73. Villar, J., Abdel-Aleem, H., Merialdi, M., Mathai, M. et al., World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. Am. J. Obstet. Gynecol. 2006, 194, 639-649.
74. Seely, E. W., Calciotropic hormones in preeclampsia: a renewal of interest. J. Clin. Endocrinol. Metab. 2007, 92, 3402-3403.
75. Bodnar, L. M., Catov, J. M., Simhan, H. N., Holick, M. F. et al., Maternal vitamin D deficiency increases the risk of preeclampsia. J. Clin. Endocrinol. Metab. 2007, 92, 3517-3522.
76. Magnu, P., Eskild, A., Seasonal variation in the occurrence of pre-eclampsia. BJOG 2001, 108, 1116-1119.
77. Ros, H. S., Cnattingius, S., Lipworth, L., Comparison of risk factors for preeclampsia and gestational hypertension in a population-based cohort study. Am. J. Epidemiol. 1998, 147, 1062-1070.
78. MacKay, A. P., Berg, C. J., Atrash, H. K., Pregnancy-related mortality from preeclampsia and eclampsia. Obstet. Gynecol. 2001, 97, 533-538.
79. Mostello, D., Catlin, T. K., Roman, L., Holcomb, W. L., Jr. et al., Preeclampsia in the parous woman: who is at risk? Am. J. Obstet. Gynecol. 2002, 187, 425-429.
80. Hypponen, E., Laara, E., Reunanen, A., Jarvelin, M. R. et al., Intake of vitamin D and risk of type 1 diabetes: a birthcohort study. Lancet 2001, 358, 1500-1503.
81. Zipitis, C. S., Akobeng, A. K., Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch. Dis. Child. 2008, 93, 512-517.
82. Merlino, L. A., Curtis, J., Mikuls, T. R., Cerhan, J. R. et al., Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum. 2004, 50, 72-77.
83. Hypponen, E., Vitamin D for the prevention of preeclampsia? A hypothesis. Nutr. Rev. 2005, 63, 225-232.
84. Vince, G. S., Starkey, P. M., Austgulen, R., Kwiatkowski, D. et al., Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with preeclampsia. Br. J. Obstet. Gynaecol. 1995, 102, 20-25.
85. Saito, S., Sakai, M., Sasaki, Y., Tanebe, K. et al., Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin. Exp. Immunol. 1999, 117, 550-555.
86. Laskowska, M., Leszczynska-Gorzelak, B., Laskowska, K., Oleszczuk, J., Evaluation of maternal and umbilical serum TNFalpha levels in preeclamptic pregnancies in the intrauterine normal and growth-restricted fetus. J. Matern. Fetal Neonatal Med. 2006, 19, 347-351.
87. Diaz, L., Noyola-Martinez, N., Barrera, D., Hernandez, G. et al., Calcitriol inhibits TNF-alpha-induced inflammatory cytokines in human trophoblasts. J. Reprod. Immunol. 2009, 81, 17-24.
88. Diaz, L., Arranz, C., Avila, E., Halhali, A. et al., Expression and activity of 25-hydroxyvitamin D-1 alpha-hydroxylase are restricted in cultures of human syncytiotrophoblast cells from preeclamptic pregnancies. J. Clin. Endocrinol. Metab. 2002, 87, 3876-3882.
89. Fischer, D., Schroer, A., Ludders, D., Cordes, T. et al., Metabolism of vitamin D3 in the placental tissue of normal and preeclampsia complicated pregnancies and premature births. Clin. Exp. Obstet. Gynecol. 2007, 34, 80-84.
90. Haugen, M., Brantsaeter, A. L., Trogstad, L., Alexander, J. et al., Vitamin D supplementation and reduced risk of preeclampsia in nulliparous women. Epidemiology 2009, 20, 720-726.
91. Halhali, A., Diaz, L., Avila, E., Ariza, A. C. et al., Decreased fractional urinary calcium excretion and serum 1,25-dihydroxyvitamin D and IGF-I levels in preeclampsia. J. Steroid Biochem. Mol. Biol. 2007, 103, 803-806.
92. Hypponen, E., Hartikainen, A. L., Sovio, U., Jarvelin, M. R. et al., Does vitamin D supplementation in infancy reduce the risk of pre-eclampsia? Eur. J. Clin. Nutr. 2007, 61, 1136-1139.
93. Olsen, S. F., Secher, N. J., A possible preventive effect of low-dose fish oil on early delivery and pre-eclampsia: indications from a 50-year-old controlled trial. Br. J. Nutr. 1990, 64, 599-609.
94. Marya, R. K., Rathee, S., Manrow, M., Effect of calcium and vitamin D supplementation on toxaemia of pregnancy. Gynecol. Obstet. Invest. 1987, 24, 38-42.
95. Metzger, B. E., Coustan, D. R., Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care 1998, 21, B161-B167.
96. Reece, E. A., Leguizamon, G., Wiznitzer, A., Gestational diabetes: the need for a common ground. Lancet 2009, 373, 1789-1797.
97. Teegarden, D., Donkin, S. S., Vitamin D: emerging new roles in insulin sensitivity. Nutr. Res. Rev. 2009, 22, 82-92.
98. Zhang, C., Qiu, C., Hu, F. B., David, R. M. et al., Maternal plasma 25-hydroxyvitamin D concentrations and the risk for gestational diabetes mellitus. PLoS One 2008, 3, e3753.
99. Clifton-Bligh, R. J., McElduff, P., McElduff, A., Maternal vitamin D deficiency, ethnicity and gestational diabetes. Diabet. Med. 2008, 25, 678-684.
100. Maghbooli, Z., Hossein-Nezhad, A., Karimi, F., Shafaei, A. R. et al., Correlation between vitamin D3 deficiency and insulin resistance in pregnancy. Diabetes Metab. Res. Rev. 2008, 24, 27-32.
101. Allsworth, J. E., Peipert, J. F., Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data. Obstet. Gynecol. 2007, 109, 114-120.
102. Svare, J. A., Schmidt, H., Hansen, B. B., Lose, G., Bacterial vaginosis in a cohort of Danish pregnant women: prevalence and relationship with preterm delivery, low birthweight and perinatal infections. BJOG 2006, 113, 1419-1425.
103. Bodnar, L. M., Krohn, M. A., Simhan, H. N., Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy. J. Nutr. 2009, 139, 1157-1161.
104. McGuire Davis, L., Chang, S. C., Mancini, J., Nathanson, M. S. et al., Vitamin D insufficiency is prevalent among pegnant African American adolescents. J. Pediatr. Adolesc. Gynecol. 2010, 23, 45-52.
105. Olausson, H., Laskey, M. A., Goldberg, G. R., Prentice, A., Changes in bone mineral status and bone size during pregnancy and the influences of body weight and calcium intake. Am. J. Clin. Nutr. 2008, 88, 1032-1039.
106. More, C., Bettembuk, P., Bhattoa, H. P., Balogh, A., The effects of pregnancy and lactation on bone mineral density. Osteoporos. Int. 2001, 12, 732-737.
107. Javaid, M. K., Crozier, S. R., Harvey, N. C., Taylor, P. et al., Maternal and seasonal predictors of change in calcaneal quantitative ultrasound during pregnancy. J. Clin. Endocrinol. Metab. 2005, 90, 5182-5187.
108. Mahon, P., Harvey, N., Crozier, S., Inskip, H. et al., Low maternal vitamin D status and fetal bone development: cohort study. J. Bone Miner. Res. 2009, 25, 11-13.
109. Merewood, A., Mehta, S. D., Chen, T. C., Bauchner, H. et al., Association between vitamin D deficiency and primary cesarean section. J. Clin. Endocrinol. Metab. 2009, 94, 940-945.
110. Morley, R., Carlin, J. B., Pasco, J. A., Wark, J. D., Maternal 25-hydroxyvitamin D and parathyroid hormone concentrations and offspring birth size. J. Clin. Endocrinol. Metab. 2006, 91, 906-912.
111. Mannion, C. A., Gray-Donald, K., Koski, K. G., Association of low intake of milk and vitamin D during pregnancy with decreased birth weight. CMAJ 2006, 174, 1273-1277.
112. Gale, C. R., Robinson, S. M., Harvey, N. C., Javaid, M. K. et al., Maternal vitamin D status during pregnancy and child outcomes. Eur. J. Clin. Nutr. 2008, 62, 68-77.
113. Scholl, T. O., Chen, X., Vitamin D intake during pregnancy: association with maternal characteristics and infant birth weight. Early Hum. Dev. 2009, 85, 231-234.
114. Brooke, O. G., Butters, F., Wood, C., Intrauterine vitamin D nutrition and postnatal growth in Asian infants. Br. Med. J. (Clin. Res. Ed.) 1981, 283, 1024.
115. Weiler, H., Fitzpatrick-Wong, S., Veitch, R., Kovacs, H. et al., Vitamin D deficiency and whole-body and femur bone mass relative to weight in healthy newborns. CMAJ 2005, 172, 757-761.
116. Morley, R., Carlin, J. B., Pasco, J. A., Wark, J. D. et al., Maternal 25-hydroxyvitamin D concentration and offspring birth size: effect modification by infant VDR genotype. Eur. J. Clin. Nutr. 2009, 63, 802-804.
117. Brown, J., Bianco, J. I., McGrath, J. J., Eyles, D. W., 1,25- dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci. Lett. 2003, 343, 139-143.
118. Nibbelink, K. A., Tishkoff, D. X., Hershey, S. D., Rahman, A. et al., 1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte. J. Steroid Biochem. Mol. Biol. 2007, 103, 533-537.
119. Morris, G. S., Zhou, Q., Hegsted, M., Keenan, M. J., Maternal consumption of a low vitamin D diet retards metabolic and contractile development in the neonatal rat heart. J. Mol. Cell Cardiol. 1995, 27, 1245-1250.
120. Santillan, G. E., Vazquez, G., Boland, R. L., Activation of a beta-adrenergic-sensitive signal transduction pathway by the secosteroid hormone 1,25-(OH)2-vitamin D3 in chick heart. J. Mol. Cell Cardiol. 1999, 31, 1095-1104.
121. Eyles, D. W., Feron, F., Cui, X., Kesby, J. P. et al., Developmental vitamin D deficiency causes abnormal brain development. Psychoneuroendocrinology 2009, 34 (Suppl 1), S247-S257.
122. Eyles, D., Brown, J., Mackay-Sim, A., McGrath, J. et al., Vitamin D3 and brain development. Neuroscience 2003, 118, 641-653.
123. Ko, P., Burkert, R., McGrath, J., Eyles, D., Maternal vitamin D3 deprivation and the regulation of apoptosis and cell cycle during rat brain development. Brain Res. Dev. Brain Res. 2004, 153, 61-68.
124. Maka, N., Makrakis, J., Parkington, H. C., Tare, M. et al., Vitamin D deficiency during pregnancy and lactation stimulates nephrogenesis in rat offspring. Pediatr. Nephrol. 2008, 23, 55-61.
125. Doll, R., Hill, A. B., Lung cancer and other causes of death in relation to smoking; a second report on the mortality of British doctors. Br. Med. J. 1956, 2, 1071-1081.
126. Dwyer, T., Ponsonby, A. L., The decline of SIDS: a success story for epidemiology. Epidemiology 1996, 7, 323-325.
127. Nelson, H. D., Humphrey, L. L., Nygren, P., Teutsch, S. M. et al., Postmenopausal hormone replacement therapy: scientific review. JAMA 2002, 288, 872-881.
128. Lumley, J., Watson, L., Watson, M., Bower, C., Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst. Rev. 2001, CD001056.
129. Mahomed, K., Gulmezoglu, A. M., Vitamin D supplementation in pregnancy. Cochrane Database Syst. Rev. 2000, CD000228.